Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 489
0
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

How good are North American mosquitoes at spreading Zika virus?

Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

Backer Badge Funded